In KNG cells, mice, and PCOS patients, melatonin significantly increases SIRT1 expression, suppresses excessive activation of the PINK1-Parkin pathway, restores mitochondrial function, and alleviates GC damage caused by PCOS, thereby improving both in vivo and in vitro phenotypes of PCOS. This evidence concerns the gene PRKN and polycystic ovary syndrome.